Lv1
40 积分 2026-09-09 加入
[Recommendations for the diagnosis and treatment of Sjögren's syndrome in China]
7天前
已完结
Iguratimod treatment reduces disease activity in early primary Sjögren's syndrome: An open-label pilot study
13天前
已完结
[Chinese guidelines for the diagnosis and treatment of juvenile dermatomyositis]
20天前
已完结
Childhood-onset of primary Sjögren’s syndrome: phenotypic characterization at diagnosis of 158 children
1个月前
已完结
A single-center study of clinical features of pediatric Sjögren’s syndrome
1个月前
已完结
OP0076 LONG-TERM OUTCOMES OF REPEAT CYCLES OF RITUXIMAB FOR SYSTEMIC MANIFESTATIONS OF SJOGREN’S DISEASE: MULTICENTRE UK COHORT STUDY
1个月前
已关闭
Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study
1个月前
已完结
Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial
1个月前
已完结
The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus
1个月前
已完结
Navicular avascular necrosis in juvenile idiopathic arthritis
1个月前
已关闭
皖公网安备34019202002308
